Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnostic Performance of Small RNA Blood Test in Patients Undergoing Follow-up Imaging After Positive Low Dose CT Screening for Cancer of the Lung "Early Detection of Lung Cancer Based on Small RNA Signatures - Boston II"

NCT05987189 is registered in ClinicalTrials.gov with Hummingbird Diagnostics as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05987189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnostic Performance of Small RNA Blood Test in Patients Undergoing Follow-up Imaging After Positive Low Dose CT Screening for Cancer of the Lung "Early Detection of Lung Cancer Based on Small RNA Signatures - Boston II"
Lead sponsor
Hummingbird Diagnostics
Phase
Observational
Overall status
Active, not recruiting
Start date
October 18, 2023
Completion date
July 31, 2027
Enrollment
2,000 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer